Bausch Health Companies (BHC) Cost of Revenue (2009 - 2026)
Bausch Health Companies (BHC) posted Cost of Revenue of $753.0 million for Q2 2026, up 4.44% sequentially from $721.0 million in Q1 2026, and up 0.67% YoY from $748.0 million in Q2 2025.
Bausch Health Companies (BHC) Cost of Revenue (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Cost of Revenue for 18 years, with the latest figure at $753.0 million in Q2 2026.
- Quarterly Cost of Revenue rose 0.67% year-over-year to $753.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.0 billion (up 5.95% YoY) and the FY2025 annual result came in at $2.9 billion, up 8.06% from the prior year.
- Cost of Revenue grew to $753.0 million in Q2 2026 per BHC's latest filing, from $721.0 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $783.0 million in Q4 2025 and troughed at $536.0 million in Q1 2022.
- A 5-year average of $665.9 million and a median of $682.5 million in 2024 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue dropped 5.96% in 2022, then advanced 12.68% in 2023.
- Over 5 years, Cost of Revenue stood at $639.0 million in 2022, then increased by 8.76% to $695.0 million in 2023, then advanced by 2.3% to $711.0 million in 2024, then advanced by 10.13% to $783.0 million in 2025, then retreated by 3.83% to $753.0 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $753.0 million, $721.0 million, and $783.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | 753.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 753.00 Mn |
| Jun 30, 2026 | 753.00 Mn |
| Mar 31, 2026 | 721.00 Mn |
| Mar 31, 2026 | 721.00 Mn |
| Dec 31, 2025 | -4.00 Mn |
| Dec 31, 2025 | -4.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 33.00 Mn |
| Jun 30, 2025 | 33.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Sep 30, 2024 | 113.00 Mn |
| Sep 30, 2024 | 113.00 Mn |
| Dec 31, 2023 | -30.00 Mn |
| Dec 31, 2023 | -30.00 Mn |
| Sep 30, 2023 | 612.00 Mn |
| Sep 30, 2023 | 612.00 Mn |